New device expands AtriCure’s market opportunity in post-operative pain management while addressing a significant unmet clinical need Recently cleared under an FDA 510(k), the cryoXT device is ...

This transcript has been edited for clarity. Jeff Gadsden, MD: Hello, I'm Dr Jeff Gadsden, a professor of anesthesiology at Duke University Hospital in North Carolina. And with me is Dr Eliana ...

CPT copyright 2011 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association. Editor’s note: This article ...

This Collection invites original research on postoperative pain management, from studies examining strategies for preventing and assessing postoperative pain to those exploring delivery of pain ...

Acute pain management in the older adult is both challenging and rewarding. This review addresses the difficulty with assessment of pain in the older adult, variations in the pain experience of older ...

MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...

(BPT) – Ahead of surgery, it is normal to have a running list of questions. Those questions likely include learning more about the surgical procedure, the possible complications, and the pain ...

—Because moderate or severe pain is common after surgery, and can hinder postoperative outcomes, it’s critical that care teams have recommendations that can facilitate pain management throughout the ...

Liposomal bupivacaine is a long-acting local anesthetic developed for use in relieving postoperative pain, allowing drug release over up to 72 hours. Studies have shown that liposomal bupivacaine can ...

Routine head and neck procedures, such as removal of tonsils and adenoids and the placement of ear tubes, may cause moderate to severe pain in pediatric patients. Over-the-counter analgesics (aspirin ...

MASON, Ohio, September 09, 2025--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) ...